Ashwani Kumar's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publication (1)
In 1995, Amidon and coworkers introduced the biopharmaceutical classification system (BCS) to reduce the need for in vivo bioequivalency studies, utilization of in vitro dissolution tests as a surrogate for in vivo bioequivalence studies. The principles of the BCS classification system can be applied to NDA and ANDA approvals as well as to scaleup...
Citations
... В литературных источниках каптоприл иногда относят к классу I (высокая растворимость и высокая проницаемость) по биофармацевтической классификационной системе (БКС) [6]. Однако ряд авторов относят каптоприл к классу III по БКС (высокая растворимость и низкая проницаемость) [7][8][9]. БКС предполагает, что для лекарств с высокой растворимостью и высокой проницаемостью (класс I) и, в некоторых случаях, для лекарств с высокой растворимостью и низкой проницаемостью (класс III) растворение более 85 % за 15 минут может гарантировать, что биодоступность лекарства не ограничена растворением Методы анализа лекарственных средств Analytical Methods субстанции. В этих случаях этапом, лимитирующем скорость всасывания лекарственного средства, является опорожнение желудка. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272199441448983-1441908812664_Q64/Mohd-Yasir.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/11431281091419789-1666457902769_Q64/Madeeha-Asif.jpg)
